Healthcare Services
Allen & Overy can provide legal services creating a solid foundation for your healthcare infrastructure projects.
Development and provision of specialised healthcare infrastructure is one of the key themes in modern times and requires specialist advice. The unique issues raised by the public service nature of hospitals, nursing homes, rehabilitation centres, clinics, academic and commercial R&D facilities always challenge investors, sponsors and lenders. As a global firm, we can successfully guide you through all stages of the lifecycle of healthcare infrastructure projects. In the healthcare infrastructure sector, we regularly advise on lettings and leasings, development, planning and construction, environmental issues and implications, private/public partnerships, including public procurement, transitional employment issues, commercial agreements with stakeholders, outsourcing, data protection and privacy, strategic licensing and collaboration agreements, global joint ventures, M&A and restructuring.
Explore our sectors
Meet our lawyers
News & insights
News: 12 FEBRUARY 2021
Allen & Overy advises Biogroup on two high-yield bond issues and a new senior facilities agreement
PARIS – Biogroup, the leading private medical laboratory services group in France and Belgium, has successfully completed through its two main subsidiaries the issuance of EUR800million in aggregate…
Read more
News: 01 FEBRUARY 2021
Allen & Overy continues to make gains with FTSE clients
In the Adviser Rankings 15th anniversary guide A&O is ranked 3rd for FTSE 100 with 23 clients, up from 17 in 2010, and A&O is one of only two magic circle firms to have grown their total stock market…
Read more
Publications: 16 OCTOBER 2020
Podcast: Meet Caroline Riady - Healthcare and leadership in turbulent times
As part of our Women’s Network series, this week on G&R Airtime we are joined by Caroline Riady, CEO of Siloam Hospitals Group which is the single largest private hospital group in Indonesia.
Read more
Publications: 02 SEPTEMBER 2019
China: amendment to Drug Administration Law
On August 26, 2019, the China’s National People’s Congress passed the amended Drug Administration Law (the Amended DAL) which will take effect on December 1.
Read moreDownload our sector brochure
